Skip Navigation
Skip to contents

J Korean Acad Nurs : Journal of Korean Academy of Nursing

OPEN ACCESS

Articles

Page Path
HOME > J Korean Acad Nurs > Volume 43(3); 2013 > Article
Original Article
Effect of Anorexia and Neuropathic Pain Induced by Cisplatin on Hindlimb Muscles of Rat
Gee Su Yang, Myoung-Ae Choe
Journal of Korean Academy of Nursing 2013;43(3):361-369.
DOI: https://doi.org/10.4040/jkan.2013.43.3.361
Published online: June 28, 2013

1School of Nursing, University of Maryland, Baltimore, MD, U.S.A.

2College of Nursing, Seoul National University, Seoul, Korea.

Address reprint requests to: Yang, Gee Su. School of Nursing, University of Maryland, 655 West Lombard Street, Room 404, Baltimore, MD 21201, U.S.A. Tel: +1-310-424-0756, Fax: +1-410-706-3769, gsyang@umaryland.edu
• Received: September 10, 2012   • Accepted: March 22, 2013

© 2013 Korean Society of Nursing Science

  • 21 Views
  • 0 Download
  • 2 Scopus
prev next
  • Purpose
    The purpose of this study was to examine the effect of anorexia and neuropathic pain induced by cisplatin on hindlimb muscles of rats.
  • Methods
    Adult male Sprague-Dawley rats were divided into two groups, a cisplatin-treated group (n=10) and a control group (n=10). In the cisplatin-treated group, cisplatin at a dose of 2 mg/kg was injected intraperitoneally two times a week up to a cumulative dose of 20 mg/kg over 5 weeks, and in the control group saline (0.9% NaCl) was injected intraperitoneally at the same dose and duration as the cisplatin-treated group. At 34 days all rats were anesthetized, after which the soleus and plantaris muscles were dissected. Withdrawal threshold, body weight, food intake, activity, muscle weight, Type I and II fiber cross-sectional areas and myofibrillar protein content of the dissected muscles were determined.
  • Results
    Compared with the control group, the cisplatin-treated group showed significant decreases (p<.05) in withdrawal threshold, activity, food intake, body weight, Type I and II fiber cross-sectional areas, myofibrillar protein content and weight of the soleus and plantaris muscles.
  • Conclusion
    Muscular atrophy in hindlimb occurs due to anorexia and neuropathic pain induced by the cisplatin treatment.
  • 1. Adachi J, Kudo R, Asano M, Ueno Y, Hunter R, Rajendram R, et al. Skeletal muscle and liver oxysterols during fasting and alcohol exposure. Metabolism. 2006;55(1):119–127. http://dx.doi.org/10.1016/j.metabol.2005.08.003ArticlePubMed
  • 2. Ahn DW, Kim SR, Ha DH, Kim SH. Mechanism of amelioration of cisplatin nephrotoxicity by procaine treatment in mice. Korean J Anesthesiol. 2007;52(3):318–327. http://dx.doi.org/10.4097/kjae.2007.52.3.318Article
  • 3. Almurshed K, Grunewald K. The effects of dietary energy restriction on overloaded skeletal muscle in rats. Br J Nutr. 2000;84(5):697–704.ArticlePubMed
  • 4. Authier N, Gillet JP, Fialip J, Eschalier A, Coudore F. An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Exp Neurol. 2003;182(1):12–20. http://dx.doi.org/10.1016/S0014-4886(03)00003-7ArticlePubMed
  • 5. In: Carrieri-Kohlman V, Lindsey AM, West CM. editors. Pathophysiological phenomena in nursing: Human response to illness. 3rd ed. Philadelphia, PA: Saunders; 2003.
  • 6. Choe MA, An GJ. Effects of nitric oxide synthase inhibitor on hindlimb muscles in rats with neuropathic pain induced by unilateral peripheral nerve injury. J Korean Acad Nurs. 2011;41(4):520–527. http://dx.doi.org/10.4040/jkan.2011.41.4.520ArticlePubMed
  • 7. Choe MA, Ji JK, Kim EH. Effect of intermittent low-intensity, short duration exercise on Type II muscle of suspended rats. J Nurs Acad Soc. 1995;25(2):193–209.ArticlePDF
  • 8. Choe MA, Kim KH, An GJ, Lee KS, Choi JA. Hindlimb muscle atrophy of rat induced by neuropathic pain. J Korean Biol Nurs Sci. 2008;10(1):88–95.
  • 9. Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001;19(9):2381–2389.ArticlePubMed
  • 10. Gandara DR, Perez EA, Phillips WA, Lawrence HJ, DeGregorio M. Evaluation of cisplatin dose intensity: Current status and future prospects. Anticancer Res. 1989;9(4):1121–1128.PubMed
  • 11. Holecek M. Effect of starvation on branched-chain alpha-keto acid dehydrogenase activity in rat heart and skeletal muscle. Physiol Res. 2001;50(1):19–24.PubMed
  • 12. Houston ME. Biochemistry primer for exercise science. 2nd ed. Champaign, IL: Human Kinetics; 2001.
  • 13. In: Kang YH. editor. Encyclopedia of life science. Seoul: Academybook; 2008.
  • 14. Kim JY. Effects of short-term undernutrition on type I and II muscles in rat. Seoul, Seoul National University. 2005;Unpublished master's thesis.
  • 15. Kim TK, Kim YS, Yoon JR, Han IS, Kim JS, Lee CW. The effect of an intraperitoneal injection of ketamine and ketorolac on mechanical allodynia in rats with spinal nerve ligation. Korean J Anesthesiol. 2004;46(6):719–723.Article
  • 16. Kim YB, Choe MA. Effect of decreased locomotor activity on hindlimb muscles in a rat model of Parkinson's disease. J Korean Acad Nurs. 2010;40(4):580–588. http://dx.doi.org/10.4040/jkan.2010.40.4.580ArticlePubMed
  • 17. Kohn DF, Wixson SK, White WJ, Benson GJ. Anesthesia and analgesia in laboratory animals. San Diego, CA: Academic Press; 1997.
  • 18. Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Røth M, Krarup C. Neuronal involvement in cisplatin neuropathy: Prospective clinical and neurophysiological studies. Brain. 2007;130(Pt 4):1076–1088. http://dx.doi.org/10.1093/brain/awl356ArticlePubMed
  • 19. Lee DH. The clinical neurology II. Seoul: Korea University Press; 2003.
  • 20. Lieu FK, Powers SK, Herb RA, Criswell D, Martin D, Wood C, et al. Exercise and glucocorticoid-induced diaphragmatic myopathy. J Appl Physiol. 1993;75(2):763–771.ArticlePubMed
  • 21. McLoughlin DM, Wassif WS, Morton J, Spargo E, Peters TJ, Russell GF. Metabolic abnormalities associated with skeletal myopathy in severe anorexia nervosa. Nutrition. 2000;16(3):192–196.ArticlePubMed
  • 22. Nicolao P, Giometto B. Neurological toxicity of ifosfamide. Oncology. 2003;65:Suppl 2. 11–16. http://dx.doi.org/73352ArticlePubMedPDF
  • 23. Park Y, Kim YH. Chemotherapy related oral and gastrointestinalmucositis. J Korean Med Assoc. 2009;52(9):897–906. http://dx.doi.org/10.5124/jkma.2009.52.9.897Article
  • 24. Prado CM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, Reiman T, et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res. 2007;13(11):3264–3268. http://dx.doi.org/10.1158/1078-0432.ccr-06-3067ArticlePubMedPDF
  • 25. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinaltracts: A population-based study. Lancet Oncol. 2008;9(7):629–635. http://dx.doi.org/10.1016/s1470-2045(08)70153-0ArticlePubMed
  • 26. Sweeney CW. Understanding peripheral neuropathy in patients with cancer: Background and patient assessment. Clin J Oncol Nurs. 2002;6(3):163–166. http://dx.doi.org/10.1188/02.cjon.163-166ArticlePubMed
  • 27. Taillandier D, Aurousseau E, Meynial-Denis D, Bechet D, Ferrara M, Cottin P, et al. Coordinate activation of lysosomal, Ca 2±activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem J. 1996;316(Pt 1):65–72.ArticlePubMedPMCPDF
  • 28. Vera G, Castillo M, Cabezos PA, Chiarlone A, Martín MI, Gori A, et al. Enteric neuropathy evoked by repeated cisplatin in the rat. Neurogastroenterol Motil. 2011;23(4):370–378. e162–e163. http://dx.doi.org/10.1111/j.1365-2982.2011.01674.xArticlePubMed
  • 29. Vera G, Chiarlone A, Martn MI, Abalo R. Altered feeding behaviour induced by long-term cisplatin in rats. Auton Neurosci. 2006;126-127:81–92. http://dx.doi.org/10.1016/j.autneu.2006.02.011ArticlePubMed
  • 30. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008;13(1):27–46. http://dx.doi.org/10.1111/j.1529-8027.2008.00156.xArticlePubMed
  • 31. Yakabi K, Sadakane C, Noguchi M, Ohno S, Ro S, Chinen K, et al. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology. 2010;151(8):3773–3782. http://dx.doi.org/10.1210/en.2010-0061ArticlePubMedPDF
  • 32. Yang YH. Anorexia, nausea and vomiting, and food intake patterns in patients on chemotherapy. J Korean Acad Fundam Nurs. 2004;11(2):177–185.
Figure 1
Changes of withdrawal thresholds in the control and cisplatin groups.
jkan-43-361-g001.jpg
Table 1
Experimental Procedures
jkan-43-361-i001.jpg
Table 2
Experimental Results in the Control and Cisplatin Groups
jkan-43-361-i002.jpg

NP=Neuropathic pain; *Significantly different between the control and cisplatin groups (p<.05).

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  

      • Cite
        CITE
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Effect of Anorexia and Neuropathic Pain Induced by Cisplatin on Hindlimb Muscles of Rat
        J Korean Acad Nurs. 2013;43(3):361-369.   Published online June 28, 2013
        Close
      • XML DownloadXML Download
      Figure
      • 0
      We recommend
      Effect of Anorexia and Neuropathic Pain Induced by Cisplatin on Hindlimb Muscles of Rat
      Image
      Figure 1 Changes of withdrawal thresholds in the control and cisplatin groups.
      Effect of Anorexia and Neuropathic Pain Induced by Cisplatin on Hindlimb Muscles of Rat

      Experimental Procedures

      Experimental Results in the Control and Cisplatin Groups

      NP=Neuropathic pain; *Significantly different between the control and cisplatin groups (p<.05).

      Table 1 Experimental Procedures

      Table 2 Experimental Results in the Control and Cisplatin Groups

      NP=Neuropathic pain; *Significantly different between the control and cisplatin groups (p<.05).


      J Korean Acad Nurs : Journal of Korean Academy of Nursing
      Close layer
      TOP